150 related articles for article (PubMed ID: 22457805)
1. Maxadilan prevents apoptosis in iPS cells and shows no effects on the pluripotent state or karyotype.
Zhao Z; Yu R; Yang J; Liu X; Tan M; Li H; Chen J
PLoS One; 2012; 7(3):e33953. PubMed ID: 22457805
[TBL] [Abstract][Full Text] [Related]
2. Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons.
Tatsuno I; Uchida D; Tanaka T; Saeki N; Hirai A; Saito Y; Moro O; Tajima M
Brain Res; 2001 Jan; 889(1-2):138-48. PubMed ID: 11166697
[TBL] [Abstract][Full Text] [Related]
3. PAC1R agonist maxadilan enhances hADSC viability and neural differentiation potential.
Guo X; Yu R; Xu Y; Lian R; Yu Y; Cui Z; Ji Q; Chen J; Li Z; Liu H; Chen J
J Cell Mol Med; 2016 May; 20(5):874-90. PubMed ID: 26798992
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of guinea pig intrinsic cardiac neurons by the PAC1 agonists maxadilan and pituitary adenylate cyclase-activating polypeptide 27 (PACAP27).
Hoover DB; Tompkins JD; Parsons RL
J Pharmacol Exp Ther; 2009 Oct; 331(1):197-203. PubMed ID: 19602551
[TBL] [Abstract][Full Text] [Related]
5. The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
Vaczy A; Reglodi D; Somoskeoy T; Kovacs K; Lokos E; Szabo E; Tamas A; Atlasz T
J Mol Neurosci; 2016 Oct; 60(2):186-94. PubMed ID: 27566170
[TBL] [Abstract][Full Text] [Related]
6. Maxadilan is a specific agonist and its deleted peptide (M65) is a specific antagonist for PACAP type 1 receptor.
Uchida D; Tatsuno I; Tanaka T; Hirai A; Saito Y; Moro O; Tajima M
Ann N Y Acad Sci; 1998 Dec; 865():253-8. PubMed ID: 9928019
[TBL] [Abstract][Full Text] [Related]
7. Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1-CXCR1/2-pathway.
Svensjö E; Saraiva EM; Amendola RS; Barja-Fidalgo C; Bozza MT; Lerner EA; Teixeira MM; Scharfstein J
Microvasc Res; 2012 Mar; 83(2):185-93. PubMed ID: 22036674
[TBL] [Abstract][Full Text] [Related]
8. Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice.
Yokai M; Kurihara T; Miyata A
Mol Pain; 2016; 12():. PubMed ID: 27175011
[TBL] [Abstract][Full Text] [Related]
9. PACAP promotes neural stem cell proliferation in adult mouse brain.
Mercer A; Rönnholm H; Holmberg J; Lundh H; Heidrich J; Zachrisson O; Ossoinak A; Frisén J; Patrone C
J Neurosci Res; 2004 Apr; 76(2):205-15. PubMed ID: 15048918
[TBL] [Abstract][Full Text] [Related]
10. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor.
Soares MB; Titus RG; Shoemaker CB; David JR; Bozza M
J Immunol; 1998 Feb; 160(4):1811-6. PubMed ID: 9469441
[TBL] [Abstract][Full Text] [Related]
11. Maxadilan activates PAC1 receptors expressed in Xenopus laevis xelanophores.
Pereira P; Reddy VB; Kounga K; Bello Y; Lerner E
Pigment Cell Res; 2002 Dec; 15(6):461-6. PubMed ID: 12453189
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland homogenates of Lutzomyia longipalpis and its vasodilatory peptide maxadilan cause plasma leakage via PAC1 receptor activation.
Svensjö E; Saraiva EM; Bozza MT; Oliveira SM; Lerner EA; Scharfstein J
J Vasc Res; 2009; 46(5):435-46. PubMed ID: 19176972
[TBL] [Abstract][Full Text] [Related]
13. Maxadilan, the PAC1 receptor, and leishmaniasis.
Reddy VB; Li Y; Lerner EA
J Mol Neurosci; 2008 Nov; 36(1-3):241-4. PubMed ID: 18509762
[TBL] [Abstract][Full Text] [Related]
14. PACAP-38 and PACAP(6-38) Degranulate Rat Meningeal Mast Cells
Pedersen SH; la Cour SH; Calloe K; Hauser F; Olesen J; Klaerke DA; Jansen-Olesen I
Front Cell Neurosci; 2019; 13():114. PubMed ID: 30983973
[TBL] [Abstract][Full Text] [Related]
15. PACAP protects against TNFα-induced cell death in olfactory epithelium and olfactory placodal cell lines.
Kanekar S; Gandham M; Lucero MT
Mol Cell Neurosci; 2010 Dec; 45(4):345-54. PubMed ID: 20654718
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist.
Moro O; Wakita K; Ohnuma M; Denda S; Lerner EA; Tajima M
J Biol Chem; 1999 Aug; 274(33):23103-10. PubMed ID: 10438479
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.
Li M; Funahashi H; Mbikay M; Shioda S; Arimura A
Endocrine; 2004 Feb; 23(1):59-75. PubMed ID: 15034198
[TBL] [Abstract][Full Text] [Related]
18. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress.
Piro S; Anello M; Di Pietro C; Lizzio MN; Patanè G; Rabuazzo AM; Vigneri R; Purrello M; Purrello F
Metabolism; 2002 Oct; 51(10):1340-7. PubMed ID: 12370856
[TBL] [Abstract][Full Text] [Related]
19. Long-term administration of maxadilan improves glucose tolerance and insulin sensitivity in mice.
Yu R; Yi T; Xie S; Hong A
Peptides; 2008 Aug; 29(8):1347-53. PubMed ID: 18440093
[TBL] [Abstract][Full Text] [Related]
20. Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastoma cells.
Eggenberger M; Born W; Zimmermann U; Lerner EA; Fischer JA; Muff R
Neuropeptides; 1999 Apr; 33(2):107-14. PubMed ID: 10657479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
